2026 Speakers
Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center, United States
Nadav Ahituv, Director, Institute for Human Genetics, UCSF, United States
Hamza Ahsan, Senior Manager MSAT, Vaxcyte, United States
Sonia Appel, Founder and Principal, Alismere, United States
Philip Arlen, President And Chief Executive Officer, Precision Biologics Inc, United States
Brian Avanzino, Director of Discovery Research, Rondo Therapeutics, United States
Parastoo Azadi, Technical Director Of Analytical Services And Senior Research Scientist, Complex Carbohydrate Research Center, United States
Aniket Badkar, Director, Formulation and Drug Product Development, Vir Biotechnology, Inc., United States
Julio Baez, Bioengineering Industrial Advisor, University of California San Diego, United States
Jason Beckwith, Professor, University of Dundee, United Kingdom
Alexey Berezhnoy, Director of Immunology, Zymeworks Inc, United States
Maroun Beyrouthy, Senior Advisor, Eli Lilly, United States
Nina Blazeska, Project Manager, La Jolla Institute for Allergy and Immunology, United States
Zachary Bornholdt, Chief Executive Officer, Eitr Biologics, United States
Ale Brown, CEO, Kirke Consulting
Omer Butt, Vice President, Regulatory Affairs, CytoImmune Therapeutics, Puerto Rico
Stacy Capehart, Director Data Science / Head of Lab Operations, Mosaic Biosciences
Jennifer Chain, CSM Industry Advocate, The Leukopak Lady, United States
Prasun Chakraborty, Founder & CEO, Genevation LTD, United Kingdom
Melody Chang, VP of Pharmacy Operations, American oncology network, United States
Jake Chen, Endowed Professor and Director, University of Alabama at Birmingham, United States
Xiaocheng Chen, Vice President, Antibody Therapeutics, Virtuoso Therapeutics, United States
Qiang Chen, Professor, Biodesign Institute at Arizona State University, United States
David Chen, Executive Director, Pharmacy Operations, Clinical Utilization and Intelligence, The Permanente Medical Group Inc, United States
Mark Chiu, President, Tavotek Biotherapeutics, United States
Daniela Cipolletta, Senior Director of Immunology, Seismic Therapeutic, United States
Brittney Cottrell, San Diego State University, United States
Brandon DeKosky, Associate Professor, Massachusetts Institute of Technology / The Ragon Institute, United States
Vaibhav Deokar, Principal Scientist, LUPIN LIMITED, India
Hans Van Der Vliet, Medical Oncologist, Amsterdam UMC, Netherlands
Genevieve Desjardins, Principal Scientist in Protein Engineering, Zymeworks Inc, Canada
Robert Dillman, Chief Medical Officer, AIVITA Biomedical, Inc., United States
Hana Do, Research Analyst, Tufts Center for the Study of Drug Development, United States
Anselm Ebert, Director Business Development, H and T Presspart Manufacturing, Germany
Kamal Egodage, Founder and President, Lasanth Consulting, United States
Wendy Epstein, Professor of Law and Associate Dean of Research and Faculty Developmen, DePaul University, United States
Ugur Eskiocak, CEO, Voro Therapeutics, Inc, United States
Mourad Farouk Rezk, Independent Global Biotech and Biosimilars Executive, Independent, Switzerland
Dana Filoti, Associate Director Analytical Development and Digital Strategy, Abbvie, United States
Gordon Freeman, Researcher, Dana Farber Cancer Institute, United States
Ana Garcia, Process Development Engineer II, Regeneron, United States
Jorge García, CEO and Founder, Patagonia Healthcare, United States
Marvin Gee, Chief Research Officer, 3T Biosciences, United States
Huub Gelderblom, Director, Fred Hutch, United States
Rafa Gonzalez, Field Application Specialist, Ecolab, United States
Davis Goodnight, Senior Scientist, A-Alpha Bio, United States
Scott Greilach, Senior Scientist, Immunis Inc., United States
Rajarsi Gupta, Assistant Professor, Stony Brook Medicine, United States
Sanjeev Gupta, Sr. Vice President and Head -Biosimilar (R&D, Mfg. and BD), Ipca Laboratories Ltd, India
Ana Isabel Gutiérrez López, Global Business Development Manager, H and T Presspart Manufacturing, Spain
Chad Hall, Principal Scientist - Research & Development, Catalent
Lance Hepler, CIO, Infinimmune, United States
Kenneth Holbourn, Senior Director Process Development, FUJIFILM Biotechnologies, United Kingdom
Michelle Holm, Senior Director - Supply Chain, Mayo Clinic, United States
Heather Horne, Associate Director, Downstream Process Development, KBI Biopharma Inc.
Changyun Hu, Co-Founder and CSO, ADEPT THERAPEUTICS INC, United States
Laurent Humeau, CSO, Inovio Pharmaceuticals, United States
Sophia Humphreys, Vice President, Health System Strategy and Innovation, MJH Life Science, United States
Clayton Irvine, Senior Manager, Oncology Cancer Care, Mayo Clinic, United States
Vibha Jawa, CSO, EpiVax Inc., United States
Jennifer Johnston, Cofounder and CEO, NysnoBio, United States
Aaron Josephson, Senior Director, Regulatory Policy, Teva Pharmaceuticals, United States
Pete Kane, Founder, Research to the People, United States
Tyler Kennedy, Senior Scientist, Bristol Myers Squibb
Zeynep Kosaloglu-Yalcin, Instructor, La Jolla Institute for Immunology
Zoran Krunic, Sr. Manager Data Science, Amgen, United States
Sonya Kumar Bharathkar, Post Doctoral Researcher, John Hopkins University, United States
Keiichiro Kushiro, Director of Research, Mucommune, United States
Jin Lee, Founder, IMIDeology, United States
Sanghoon Lee, Assistant Professor, Kennesaw State University, United States
Steve Lehrer, MD, SBLehrer LLC, United States
Sabrina Leslie, Associate Professor, The University of British Columbia, Canada
Matteo Levisetti, Chief Medical Officer, Cue Biopharma, INC, United States
Mengyue (J.P.) Li, Co-Chairman, Meridian Universal Health Group Inc. / Wharton Alumni Angels, United States
Huilan Lin, Principal Scientist, Capricor Therapeutics, Inc., United States
Cate Lockhart, Executive Director, Biologics and Biosimilars Collective Intelligence Consortium, United States
Prashant Mali, Professor, Bioengineering, University of California San Diego, United States
Mark Mamula, Professor Of Medicine Rheumatology, Yale University, United States
Jay Mandrekar, Professor Of Biostatistics And Neurology, Mayo Clinic, United States
Cheryl Marcotte, Clinical Quality leader, GSK, United States
Amy Margolies, Founder / CEO, Sunshine Theory, United States
Shamekka Marty, Patient Advocate, National Minority Health Association, United States
Alessandro Mascioni, Director of Research, Imaginab Inc, United States
Chris Mason, Professor, Cell & Gene Therapy, University College London, United Kingdom
Wyatt McDonnell, CEO, Infinimmune, United States
Rushabh Mehta, Financial Analyst, Hammerton,Inc, United States
Santosh Misal, Scientist, National Institutes of Health, United States
Christine Mitchell, Senior Scientific Fellow, Minaris Advanced Testing, United States
Ralph Morales III, Commercial Lead, Aquillius, United States
Liviu Movileanu, Professor, Department Of Physics, Syracuse University, United States
Savita Nair, Associate Director, Sangamo Therapeutics, United States
Robert Nechanitzky, Senior Scientist, Zymeworks Inc, Canada
Heather Pace, Vizient
William Paseman, Founder, rarekidneycancer.org, United States
Hetal Patel, Vice President, Medical Affairs, Celltrion Healthcare, United States
Michael Peer, Director of Computational Biology, Biolojic Design, Israel
Salome Philip, CMC Project Manager, Attralus, United States
Zoya Gluzman-Poltorak Poltorak, CEO, Forta Bio, United States
Dracey Poore, Director of Biosimilars, Cardinal Health, United States
Kamal Puri, CSO, OncoResponse, United States
Dan Qin, Scientist III, Genentech, United States
Steve Quayle, VP Research Biology & Translational Medicine, Cue Biopharma, United States
Albert Ribickas, Assistant Operations manager Cell Therapies, Moffitt Cancer Center, United States
Brandon Rice, CEO, Co-Founder, Weave Bio, United States
Jamie Rich, Associate Director ADC Research, Zymeworks Inc, Canada
Brandon Ruotolo, Professor, Michigan State University, United States
Volker Schellenberger, SVP Research Oncology, Vir Biotechnology, Inc., United States
Jan Schnitzer, Director, P.R.I.S.M., United States
Alessandro Sette, Professor, Co-Director, Center for Vaccine Innovation, La Jolla Institute for Allergy and Immunology, United States
Sanjaya Singh, Founder and Chief Scientific Officer, Third Arc Bio, United States
Jae Sly, Ceo, Pathways Preclinical Partners, United States
Jamie Spangler, Assistant Professor, John Hopkins University, United States
Heather Stephenson, Senior Scientist, Gilead Sciences, United States
Joel Sunshine, Assistant Professor, The Johns Hopkins University School of Medicine, United States
Adeleh Taghi Khani, Senior Scientist II, Quest Diagnostics, United States
Keenan Taylor, Principal Research Scientist I, Abbvie, United States
Andy Tedeschi, Vice President, Market Access and Account Management, Organon, United States
Bert Thomas, Senior Vice President Of Business Development, Bio-Thera Solutions, United States
Jakub Tomala, Assistant Research Professor, John Hopkins University, United States
Andrew Tsourkas, Professor of Bioengineering, University of Pennsylvania, United States
Ariadne Tuckmantel Bido, Senior Scientist, ScopeSys, Canada
Nimi Vashi, Co-Founder & CEO, Buzz Biolabs, United States
Jyothsna Visweswaraiah, Senior Director, Therapeutic Protein Technologies, Seismic Therapeutic, United States
Christine Von Raesfeld, Board member/advocate, The Light Collective, United States
Ryuta Wada, Research Fellow / Technology Lead, Astellas Pharma, Japan
Kim Walker, Faculty Director & Graduate Advisor Center for Regulatory Science, San Diego State University, United States
Wei Wang, Professor, University of California San Diego, United States
Danlin Yang, Vice President, Discovery & CMC Strategies and Operations, Third Arc Bio
Fan Yang, Associate Research Fellow, Pfizer, United States
Nicholas Yoder, Senior Director, Platform Development, Dyne Therapeutics, United States
XingXing Zang, Professor & Director, Albert Einstein college of Medicine, United States
Samuel Zhang, Chief Business Officer, Innovent Biologics, Inc, United States
Yue Zhao, Principal Scientist, Genentech, United States
Xi Zhao, Head, Oncology Bioinformatics, Research and Development, Abbvie, United States
Ji Zheng, Senior Director of Biologics Process R&D, Merck, United States
Sunny Zhou, Professor, Northeastern University, United States
Yu Zhou, Manager, Analytical Development, Millipore Sigma, United States
Josh Zibit, Head of Technical Development, Astellas Gene Therapies, United States
Jonathan Ziegler, ML Researcher, Cradle Bio, Switzerland
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events